LAZZAROTTO, TIZIANA
 Distribuzione geografica
Continente #
AS - Asia 15.488
NA - Nord America 14.691
EU - Europa 12.747
SA - Sud America 952
AF - Africa 689
OC - Oceania 44
Continente sconosciuto - Info sul continente non disponibili 4
Totale 44.615
Nazione #
US - Stati Uniti d'America 14.387
IT - Italia 5.181
SG - Singapore 4.221
CN - Cina 3.942
VN - Vietnam 3.735
GB - Regno Unito 1.646
SE - Svezia 1.216
DE - Germania 1.172
HK - Hong Kong 1.007
FR - Francia 684
BR - Brasile 675
IN - India 657
KR - Corea 450
RU - Federazione Russa 440
UA - Ucraina 433
NL - Olanda 407
BD - Bangladesh 381
IE - Irlanda 346
FI - Finlandia 341
JP - Giappone 262
ZA - Sudafrica 201
CA - Canada 169
CI - Costa d'Avorio 166
AT - Austria 131
CH - Svizzera 125
AR - Argentina 119
EE - Estonia 112
PH - Filippine 104
ID - Indonesia 103
BG - Bulgaria 101
JO - Giordania 100
TG - Togo 98
TH - Thailandia 98
BE - Belgio 76
MX - Messico 75
PL - Polonia 74
TR - Turchia 64
NG - Nigeria 63
SC - Seychelles 62
IQ - Iraq 61
ES - Italia 50
TW - Taiwan 50
PK - Pakistan 49
EC - Ecuador 39
AU - Australia 38
CO - Colombia 37
SA - Arabia Saudita 34
IR - Iran 33
GR - Grecia 32
LT - Lituania 31
MY - Malesia 25
RO - Romania 24
HR - Croazia 21
VE - Venezuela 21
EG - Egitto 19
UZ - Uzbekistan 19
PE - Perù 17
PT - Portogallo 17
CL - Cile 15
CZ - Repubblica Ceca 14
LB - Libano 14
PY - Paraguay 14
SK - Slovacchia (Repubblica Slovacca) 14
MA - Marocco 12
DK - Danimarca 11
RS - Serbia 11
DZ - Algeria 10
JM - Giamaica 10
KE - Kenya 9
AE - Emirati Arabi Uniti 8
DO - Repubblica Dominicana 8
GH - Ghana 8
HN - Honduras 8
KZ - Kazakistan 8
NP - Nepal 8
TN - Tunisia 8
NO - Norvegia 7
PR - Porto Rico 7
UY - Uruguay 7
GT - Guatemala 6
HU - Ungheria 6
IL - Israele 6
AF - Afghanistan, Repubblica islamica di 5
KG - Kirghizistan 5
NZ - Nuova Zelanda 5
AL - Albania 4
AZ - Azerbaigian 4
BO - Bolivia 4
CR - Costa Rica 4
CY - Cipro 4
ET - Etiopia 4
GY - Guiana 4
KW - Kuwait 4
LK - Sri Lanka 4
MD - Moldavia 4
MZ - Mozambico 4
NI - Nicaragua 4
AO - Angola 3
BH - Bahrain 3
BY - Bielorussia 3
Totale 44.542
Città #
Singapore 2.901
Ashburn 1.716
Southend 1.313
Fairfield 969
Hefei 958
Hong Kong 945
Chandler 932
Ho Chi Minh City 862
San Jose 858
Hanoi 806
Santa Clara 696
Houston 661
Bologna 558
Woodbridge 523
Beijing 465
Wilmington 465
Seattle 460
Milan 427
Rome 413
Princeton 411
Seoul 399
Boardman 384
Ann Arbor 367
Cambridge 367
Dublin 342
Dong Ket 300
Los Angeles 292
Council Bluffs 285
Dallas 281
Lauterbourg 258
Helsinki 244
New York 235
Tokyo 221
Jacksonville 205
Abidjan 166
Nanjing 155
Padova 154
Buffalo 136
Turin 136
Westminster 135
Florence 123
Da Nang 121
Haiphong 120
São Paulo 118
Berlin 116
Frankfurt am Main 110
Redondo Beach 103
Amman 99
Lomé 98
Sofia 96
Chicago 93
Naples 93
Bengaluru 86
Shanghai 84
Vienna 84
Jinan 83
San Diego 80
Bern 70
Changsha 68
Shenyang 68
Verona 68
Guangzhou 67
Hangzhou 65
Redmond 65
Brussels 63
Des Moines 63
Munich 63
Bremen 62
Rimini 61
Amsterdam 60
Saint Petersburg 60
Johannesburg 58
Phoenix 57
Abeokuta 56
Toronto 56
The Dalles 53
Jakarta 51
Lappeenranta 51
London 50
Mülheim 50
Bari 49
Nuremberg 49
Hải Dương 47
Zhengzhou 47
Tianjin 46
Montreal 45
Orem 45
Hebei 44
Falkenstein 40
Bangkok 39
Brooklyn 39
Can Tho 39
Modena 39
Mexico City 38
Medford 37
Redwood City 37
Atlanta 36
Biên Hòa 36
Catania 36
Nanchang 35
Totale 26.316
Nome #
Outcome delle gravidanze con infezione non primaria da CMV 2.359
La gestione clinica dell’infezione da citomegalovirus in gravidanza 482
Citomegalovirus 453
Impaired dendritic cell immunophenotype and function in heart transplant patients undergoing active cytomegalovirus infection. 371
Evaluation of the Kinetics of Antibody Response to COVID-19 Vaccine in Solid Organ Transplant Recipients: The Prospective Multicenter ORCHESTRA Cohort 328
Valacyclovir for cytomegalovirus infection in pregnancy: additional evidences, additional questions 306
Restriction Factors expression decreases in HIV-1 patients after cART 276
Infectious meningitis/encephalitis: evaluation of a rapid and fully automated multiplex PCR in the microbiological diagnostic workup 274
Absence of neuroinvasive disease in a liver transplant recipient who acquired West Nile virus (WNV) infection from the organ donor and who received WNV antibodies prophylactically. 262
Relationship between immune response to SARS-CoV2 vaccines and development of breakthrough infection in solid organ transplant recipients: the CONTRAST cohort 254
Comprehensive surgical intestinal rescue and transplantation program in adult patients: Bologna experience. 249
Clinical evaluation of the new Roche platform of serological and molecular cytomegalovirus-specific assays in the diagnosis and prognosis of congenital cytomegalovirus infection 247
Clinical utility of measuring Epstein-Barr virus-specific cell-mediated immunity after HSCT in addition to virological monitoring: results from a prospective study. 243
Understanding the evolutionary dynamics of Monkeypox virus through less explored pathways 237
Altered intracellular ATP production by activated CD4+ T-cells in very preterm infants 235
Brain damage in fetuses congenitally infected by Cytomegalovirus 232
Pathological post-mortem findings in lungs infected with SARS-CoV-2 231
Automatic environmental disinfection with hydrogen peroxide and silver ions versus manual environmental disinfection with sodium hypochlorite: A multicentre randomized before-and-after trial. 226
Acral skin eruption observed during SARS-CoV-2 pandemic: possible keratolysis exfoliativa with red palms and soles 222
Recent Advances in the Evaluation of Serological Assays for the Diagnosis of SARS-CoV-2 Infection and COVID-19 219
Blood monitoring of granzyme B and perforin expression after intestinal transplantation: considerations on clinical relevance. 214
Difference in safety and humoral response to mRNA SARS-CoV-2 vaccines in patients with autoimmune neurological disorders: the ANCOVAX study 210
Successful management of EBV-PTLD in allogeneic bone marrow transplant recipient by virological-immunological monitoring of EBV infection, prompt diagnosis and early treatment. 205
Brain ischemic injury in COVID-19-infected patients: a series of 10 post-mortem cases 205
Low-Dose Anti-T Lymphoglobulin as Prophylaxis for Graft-versus-Host Disease in Unrelated Donor Transplantations for Acute Leukemias and Myelodysplastic Syndromes. 202
Monitoring of CMV-specific cell-mediated immunity in heart transplant recipients: clinical utility of the QuantiFERON®-CMV assay for the management of post-transplant CMV infection 202
Antimicrobial Efficacy of Five Probiotic Strains Against Helicobacter Pylori 199
Histological findings in foetuses congenitally infected by cytomegalovirus. 198
SARS-CoV-2/COVID-19 testing: The tower of babel 193
Blood neurofilament light chain and S100B as biomarkers of neurological involvement and functional prognosis in COVID-19: a multicenter study 192
Daclizumab and alemtuzumab as induction agents in adult intestinal and multivisceral transplantation: rejection and infection rates in 40 recipients during the early postoperative period. 192
International consensus guidelines on the management of cytomegalovirus in solid organ transplantation. 191
Congenital Cytomegalovirus Infection: Prognostic Value of Maternal DNAemia at Amniocentesis. 191
Monitoring cytomegalovirus T-cell immunity in small bowel/multivisceral transplant recipients. 190
Atypical forms of hand, foot, and mouth disease: A prospective study of 47 Italian children 190
Early and late virological monitoring of cytomegalovirus, Epstein-Barr virus, and human herpes virus 6 infections in small bowel/multivisceral transplant recipients. 189
Congenital cytomegalovirus infection: patterns of fetal brain damage. 187
Infectious agents after liver transplant: etiology, timeline and patients' cell-mediated immunity responses. 186
Clinical phenotypes and quality of life to define post-COVID-19 syndrome: a cluster analysis of the multinational, prospective ORCHESTRA cohort 185
Very low birth weight infants born to cytomegalovirus-seropositive mothers fed with their mother's milk: a prospective study. 185
Cytomegalovirus DNA load in amniotic fluid and neonatal outcome. 185
Epidemiology of Parvovirus B19 Infection In an Italian Metropolitan Area, 2012–2024: COVID‐19 Pre‐Pandemic, Pandemic and Post‐Pandemic Trends 184
Neonatal and long-term ophthalmological findings in infants with symptomatic and asymptomatic congenital cytomegalovirus infection. 184
Cytomegalovirus and Epstein-Barr Virus DNA Kinetics in Whole Blood and Plasma of Allogeneic Hematopoietic Stem Cell Transplantation Recipients 184
Whole Genome Sequencing of a Chlamydia trachomatis Strain Responsible for a Case of Rectal Lymphogranuloma Venereum in Italy 183
Resistance to Ceftazidime/Avibactam, Meropenem/Vaborbactam and Imipenem/Relebactam in Gram-Negative MDR Bacilli: Molecular Mechanisms and Susceptibility Testing 181
Circulating extracellular particles from severe COVID-19 patients show altered profiling and innate lymphoid cell-modulating ability 180
Fetal Brain Damage in Human Fetuses with Congenital Cytomegalovirus Infection: Histological Features and Viral Tropism 180
Ultrasound prediction of symptomatic congenital cytomegalovirus infection 180
Role of cerebral ultrasound and magnetic resonance imaging in newborns with congenital cytomegalovirus infection 180
Salivary glands and human congenital cytomegalovirus infection: What happens in early fetal life? 179
Antibiotic resistance and therapy outcome in H. pylori eradication failure patients. 177
COVID-19 and the Brain: The Neuropathological Italian Experience on 33 Adult Autopsies 176
IMPATTO DELLE INDAGINI DIAGNOSTICHE DI APPROFONDIMENTO E DEL COUNSELLING SULLA PERCENTUALE DI INTERRUZIONI VOLONTARIE DI GRAVIDANZA NELLE DONNE CON RISCONTRO DI IMMUNOGLOBULINE M ANTI-CITOMEGALOVIRUS AL TEST DI SCREENING 176
Congenital cytomegalovirus infection and small for gestational age infants 176
DIAGNOSI ISTOLOGICA DI INFEZIONE FETALE DA CITOMEGALOVIRUS UMANO 175
Herpes virus in Alzheimer's disease: relation to progression of the disease 175
Outcome della gravidanza dopo riscontro precoce di vaginosi batterica. 174
Children and SARS-CoV-2 infection: innocent bystanders…until proven otherwise 174
L’INFEZIONE CONGENITA DA CYTOMEGALOVIRUS NELLA GRAVIDANZA GEMELLARE 173
Diagnosis and prognosis of congenital CMV infection: A case report and review of the literature 172
Immunosuppression Modifications Based on an Immune Response Assay: Results of a Randomized, Controlled Trial. 172
Kinetics of cytomegalovirus and Epstein-Barr virus DNA in whole blood and plasma of kidney transplant recipients: Implications on management strategies 172
Off-Label Use of Letermovir as Preemptive Anti-Cytomegalovirus Therapy in a Pediatric Allogeneic Peripheral Blood Stem Cell Transplant. 172
Long term follow-up of humoral and cellular response to mRNA-based vaccines for SARS-CoV-2 in patients with active multiple myeloma 171
Risposta immune nei feti con infezione da citomegalovirus umano e correlazione con il danno d’organo. 171
Hydroxymethyl-glutaryl coenzyme a reductase inhibition limits cytomegalovirus infection in human endothelial cells. 170
Impact of induction therapy on bacterial infections and long-term outcome in adult intestinal and multivisceral transplantation: a comparison of two different induction protocols: daclizumab vs. alemtuzumab. 170
Is CMV DNAemia an early marker of CMV colitis in patients with active ulcerative colitis? 169
A randomized trial of hyperimmune globulin to prevent congenital cytomegalovirus. 169
Monkeypox Outbreak 2022: Clinical and Virological Features of 30 Patients at the Sexually Transmitted Diseases Centre of Sant' Orsola Hospital, Bologna, Northeastern Italy 168
Cytomegalovirus gN Genotypes Distribution among Congenitally Infected Newborns and Their Relationship with Symptoms at Birth and Sequelae. 167
Clinical evaluation of the Roche Elecsys® CMV IgG Avidity assay 167
Infezione congenita da citomegalovirus umano: stato dell’arte 166
Assessment and prevention of cytomegalovirus infection in allogeneic hematopoietic stem cell transplant and in solid organ transplant: A multidisciplinary consensus conference by the Italian GITMO, SITO, and AMCLI societies. 166
Immune Monitoring Using QuantiFERON®-CMV Assay in Congenital Cytomegalovirus Infection: Correlation With Clinical Presentation and CMV DNA load 166
Congenital Human Cytomegalovirus Infection: Identification Of New Prognostic Markers Of Brain Damage In Infected Fetuses 166
Successful Treatment of Bloodstream Infection due to a KPC-Producing Klebsiella Pneumoniae Resistant to Imipenem/Relebactam in a Hematological Patient 165
Congenital cytomegalovirus infection in pregnancy and the neonate: consensus recommendations for prevention, diagnosis, and therapy. 165
Cytomegalovirus in pregnancy and the neonate 165
Measles virus and cytomegalovirus co-infection, in a child with recent SARS-CoV-2 infection, during COVID-19 pandemic: a case report 164
Non-pathogenic Neisseria species of the oropharynx as a reservoir of antimicrobial resistance: a cross-sectional study 164
Citomegalovirus 164
Antibiotic resistance and therapy for H. pylori infection in immigrant patients managed in Italy 164
Combination of Cpb-Hsp70 typing methods reveals genetic divergence between Leishmania infantum strains causing human tegumentary leishmaniasis in northern Italy and central Spain: a retrospective study 163
Study of Soluble HLA-G in Congenital Human Cytomegalovirus Infection. 162
Fetal cerebral periventricular halo at midgestation: an ultrasound finding suggestive of fetal cytomegalovirus infection. 161
Prophylaxis versus preemptive anti-cytomegalovirus approach for prevention of allograft vasculopathy in heart transplant recipients 161
Ganciclovir-Resistant Cytomegalovirus Infection in a Kidney Transplant Recipient Successfully Treated with Foscarnet and Everolimus. 161
Molecular detection and genetic characterization of circulating measles virus in northern Italy. 161
Results of intestinal and multivisceral transplantation in adult patients: Italian experience. 161
The Third International Consensus Guidelines on the Management of Cytomegalovirus in Solid-organ Transplantation 161
Cmv-specific cell-mediated immunity in immunocompetent adults with primary cmv infection: A case series and review of the literature 161
Determinants of Anti-S Immune Response at 12 Months after SARS-CoV-2 Vaccination in a Multicentric European Cohort of Healthcare Workers-ORCHESTRA Project. 160
Monkeypox virus detection in non-skin matrices: potential One Health implications 159
La progressione della coronarografia del graft è proporzionale alla severità dell'infezione da citomegalovirus nei pazienti con trapianto cardiaco. 159
Intense antiextracellular adaptive immune response to human cytomegalovirus in very old subjects with impaired health and cognitive and functional status. 159
Outbreak of a new measles B3 variant in the Roma/Sinti population with transmission in the nosocomial setting, Italy, November 2015 to April 2016 158
Meningococcal Carriage in ‘Men Having Sex With Men’ With Pharyngeal Gonorrhoea 158
A collaborative study to establish the 1st WHO International Standard for human cytomegalovirus for nucleic acid amplification technology. 157
Totale 21.775
Categoria #
all - tutte 124.829
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 124.829


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021806 0 0 0 0 0 0 0 0 0 0 0 806
2021/20223.967 258 153 237 506 348 195 106 318 176 278 814 578
2022/20234.725 420 541 251 561 378 356 195 317 769 255 377 305
2023/20242.572 150 273 204 186 213 343 241 245 97 237 178 205
2024/20257.398 383 951 589 505 997 409 502 308 220 553 545 1.436
2025/202618.354 1.512 1.843 1.586 1.323 1.713 1.005 1.794 607 3.619 1.541 1.014 797
Totale 45.582